| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.758 | 14.633 | 26.008 | 21.325 | 55.881 | 83.116 | 87.150 | 71.608 | 177.757 | 199.172 |
| Total Income - EUR | 18.195 | 14.633 | 26.060 | 21.325 | 55.881 | 83.116 | 87.150 | 71.608 | 177.779 | 199.178 |
| Total Expenses - EUR | 15.430 | 13.015 | 12.054 | 14.930 | 6.345 | 7.055 | 7.200 | 8.065 | 31.685 | 49.661 |
| Gross Profit/Loss - EUR | 2.765 | 1.618 | 14.006 | 6.395 | 49.536 | 76.061 | 79.950 | 63.543 | 146.094 | 149.517 |
| Net Profit/Loss - EUR | 2.626 | 1.492 | 13.745 | 5.976 | 47.860 | 73.567 | 77.388 | 61.870 | 144.352 | 143.660 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Simbio Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.458 | 12.902 | 10.276 | 7.723 | 22.246 | 15.528 | 9.074 | 2.973 | 13.450 | 55.203 |
| Current Assets | 7.928 | 9.193 | 23.412 | 14.322 | 33.308 | 66.277 | 73.671 | 59.584 | 110.565 | 68.444 |
| Inventories | 1.819 | 2.715 | 3.360 | 1.821 | 1.261 | 1.237 | 1.209 | 1.213 | 1.495 | 3.526 |
| Receivables | 835 | 2.243 | 7.923 | 4.679 | 5.765 | 12.277 | 36.566 | 31.564 | 89.471 | 57.371 |
| Cash | 5.274 | 4.234 | 12.130 | 7.821 | 26.282 | 52.763 | 35.896 | 26.806 | 19.599 | 7.547 |
| Shareholders Funds | 12.146 | 13.514 | 25.564 | 17.577 | 47.902 | 73.598 | 77.418 | 61.494 | 101.256 | 100.805 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.686 | 9.022 | 8.557 | 4.695 | 7.652 | 8.207 | 5.327 | 1.062 | 22.760 | 22.842 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Simbio Med S.r.l.